These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Expression of cell surface antigens by suppressor T cell hybridomas. I. Comparison of phenotype and function. Trial J; Kapp JA; Pierce CW; Shreffler DC; Sorensen CM; Waltenbaugh C J Immunol; 1983 Feb; 130(2):565-72. PubMed ID: 6217244 [TBL] [Abstract][Full Text] [Related]
4. The hybridoma technology: I. Production of monoclonal antibodies. Epstein N; Epstein M Adv Biotechnol Processes; 1986; 6():179-218. PubMed ID: 3535831 [No Abstract] [Full Text] [Related]
5. Enzyme-linked immunosorbent assay and flow cytometric methods to screen hybridoma culture supernatants for antibodies to bovine neutrophil surface antigens, and monoclonal antibody production and characterization. Salgar SK; Paape MJ; Alston-Mills B Am J Vet Res; 1993 Sep; 54(9):1415-25. PubMed ID: 8239127 [TBL] [Abstract][Full Text] [Related]
8. [Monoclonal antibodies and their potential application to medicine]. Weber S Z Erkr Atmungsorgane; 1985; 165(1):3-12. PubMed ID: 2414929 [TBL] [Abstract][Full Text] [Related]
9. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies. White J; Haskins KM; Marrack P; Kappler J J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies: technology and potential use. Antczak DF J Am Vet Med Assoc; 1982 Nov; 181(10):1005-10. PubMed ID: 6757209 [TBL] [Abstract][Full Text] [Related]
12. Changes in Lymphocyte cell surface markers in human disease states. Williams RC Clin Immunol Rev; 1981-1982; 1(3):409-69. PubMed ID: 6762279 [No Abstract] [Full Text] [Related]
13. Establishment of hybridoma cell lines secreting anti-Legionella pneumophila serogroup 1 monoclonal antibodies with immunodiagnostic potential. Sethi KK; Brandis H Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):294-8. PubMed ID: 6649980 [TBL] [Abstract][Full Text] [Related]
14. [Hybridoma-produced monoclonal antibodies: the most revolutionary technique in immunobiology (author's transl)]. Ruiz-Argüelles A Rev Invest Clin; 1982; 34(1):79-84. PubMed ID: 7046001 [No Abstract] [Full Text] [Related]
15. [Toxoplasma gondii: the characterization of an anti-P30 monoclonal antibody]. Fachado A; Fernández N; Hernández E; Fonseca L Rev Cubana Med Trop; 1996; 48(3):178-83. PubMed ID: 9805047 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effector function of rat IgG2a monoclonal anti-S. mansoni antibodies. Grzych JM; Capron M; Bazin H; Capron A J Immunol; 1982 Dec; 129(6):2739-43. PubMed ID: 7142705 [TBL] [Abstract][Full Text] [Related]
17. Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens. Kurlander RJ J Immunol; 1983 Jul; 131(1):140-7. PubMed ID: 6223069 [TBL] [Abstract][Full Text] [Related]
18. Obtention of rat monoclonal antibodies reactive with human leukaemic lymphoblasts. Lebacq AM; Bazin H Bull Cancer; 1983; 70(2):93-5. PubMed ID: 6575843 [TBL] [Abstract][Full Text] [Related]
19. A serum independent medium effective in all aspects of hybridoma technology and immunological applications. Baker P; Knoblock K; Noll L; Wyatt D; Lydersen B Dev Biol Stand; 1985; 60():63-72. PubMed ID: 3876250 [TBL] [Abstract][Full Text] [Related]
20. A killer cell protective antigen expressed by MHC-unrestricted killer hybridomas. Kubota K Cell Immunol; 1997 Oct; 181(1):50-8. PubMed ID: 9344496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]